NHS Greater Glasgow and Clyde, on behalf of west of Scotland health boards, has made history by appointing Scotland’s first consultant pharmacist within the West of Scotland Cancer network.
In a healthcare landscape that continually develops to adhere to the evolving needs of patients, the ground-breaking appointment of Jennifer Laskey marks a significant milestone in the pharmacy profession, signalling a new era of patient centred cancer care.
As a consultant pharmacist, Jennifer will lead in delivering care and improvement across health and social care systems by helping drive innovation and delivering the full potential of pharmacy care.
Jennifer’s credentials as a consultant pharmacist – accredited by the Royal Pharmaceutical Society – provides assurance to patients and other healthcare professionals that she is practicing at the appropriate level while developing her expertise across the four pillars of clinical practice, leadership, education and research.
In her new role, Jennifer is committed to ensuring patients across community, primary and acute settings have access to the highest quality care, with her work focusing on driving improvement outcomes and survival rates.
Jennifer said: “To be appointed as the first consultant pharmacist in Scotland is a highly significant landmark for the pharmacy profession.
“Cancer remains an important health priority, affecting 1 in 2 people. With improving survival rates, an increasing number of people are living with cancer.
“Within my role, I am working across community, primary, and acute care sectors to ensure that people in Scotland can access excellent cancer care now and—in the future.”
The appointment of the Scotland’s first consultant pharmacist marks a significant landmark in pharmacy care and shows the commitment across the west of Scotland to delivering the highest quality and standard of patient centred cancer care.
The Scottish Government’s Chief Pharmaceutical Officer, Professor Alison Strath said: “I am delighted to approve the first consultant pharmacist post in Scotland.
“Cancer remains a national priority and the consultant pharmacist for the West of Scotland Cancer Network will work with the wider multidisciplinary team to drive improvements in outcomes for cancer patients and lead system wide service change.”
